SELLAS Life Sciences

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S.

CEO

Angelos M. Stergiou

CEOAngelos M. Stergiou

Employees

Employees11

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2006

Founded2006

Employees

Employees11

SLS Key Statistics

Market cap

44.80M

Market cap44.80M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

91.56K

Average volume91.56K

High today

$2.22

High today$2.22

Low today

$2.16

Low today$2.16

Open price

$2.22

Open price$2.22

Volume

29.17K

Volume29.17K

52 Week high

$9.78

52 Week high$9.78

52 Week low

$1.92

52 Week low$1.92

SLS Earnings

-$1.05

-$0.70

-$0.35

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 11, After Hours

ActualExpected Nov 11, After Hours

SELLAS Life Sciences

Why Robinhood?

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S. Show more

SLS Key Statistics

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S.